CMS recently issued a statement saying that it's continuing the Medicare Drug Price Negotiation Program but is leaving the door open for potential changes. Experts weighed in on what changes could be ...

Having timely, accurate data is essential for healthcare practices to boost operational efficiency. Scheduling appointments or managing provider and staff workloads are informed by the metrics a ...

Member engagement is a critical function of any health plan’s outcomes improvement strategy. How members interact with their health plans directly impacts satisfaction, health outcomes, and ...

Fay, a digital nutrition therapy startup, has secured $50 million in Series B funding led by Goldman Sachs, the company announced on Wednesday. San Francisco-based Fay connects people to a network ...

The $5 trillion cost of healthcare has pushed Americans to the brink. Despite calls for consumers to take a more active role in reducing healthcare costs, the ugly truth is that the information ...

Bain Capital, an investment firm that has spread its life sciences bets mainly across companies developing novel new medicines, is acquiring Mitsubishi Tanabe Pharma Corporation in a multi-billion ...

Robert Califf addressed a range of issues, including AI, lack of nutrition resources at the FDA and how he evaluates the progress of precision medicine at the Precision Medicine World Conference in ...

Many predicted increased M&A activity in the digital health space in 2025, and so far they seem to be right. On Wednesday, telemedicine company Teladoc Health announced that it plans to acquire ...

From record-high drug shortages to the explosive popularity of GLP-1 medications and the intensifying battle over the 340B drug discount program, many of the biggest healthcare stories of 2024 ...

Healthcare organizations have to balance the need to support data collection with staff workloads. More healthcare practices are working with health tech vendors to digitize their workflows and ...

A Denali Therapeutics drug for the rare enzyme deficiency Hunter syndrome is still in pivotal testing, but the company has guidance from the FDA on a pathway to get this therapy to the market sooner.

Last year, more than 30 million American adults believed they had a substance use problem, while one out of five young people who suffered a major depressive episode also struggled with substance ...